[1]张霈,王娅囡,叶航,等.炎症标志物检测联合术前多模态MRI特征预测肝细胞癌微血管侵犯[J].放射学实践, 2023, 38(9): 1129-1133. DOI:10.13609/j.cnki.1000-0313.2023.09.008.
[2]刘子蔚,杨少民,张榕,等.钆塞酸二钠增强多模态MRI联合临床特征同时预测肝细胞癌CK19表达及微血管侵犯的价值[J].放射学实践, 2024, 39(5): 598-604. DOI:10.13609/j.cnki.1000-0313.2024.05.006.
[3]Dengfeng L, Qing P, Leyao, et al. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9[J]. Eur Radiol, 2024, 34(1): 509-524. DOI: 10.1007/s00330-023-09980-8.
[4]莫志英.多模态MRI术前预测肝细胞癌术后复发的研究进展[J].实用放射学杂志, 2022, 38(2): 331-334. DOI:10.3969/j.issn.1002-1671.2022.02.036.
[5]胡光超,张倩倩,毛宁,等.术前MRI预测肝细胞癌微血管侵犯研究进展[J].磁共振成像, 2022, 13(2): 159-162. DOI:10.12015/issn.1674-8034.2022.02.040.
[6]吴杰,肖安岭,刘涛,等.多模态MRI对孤立性肝细胞癌微血管侵犯病理相关性研究[J].实用放射学杂志, 2022, 38(11): 1803-1806. DOI:10.3969/j.issn.1002-1671.2022.11.017.
[7]Endo Y, Alaimo L, Lima H A, et al. A novel online calculator to predict risk of microvascular invasion in the preoperative setting for hepatocellular carcinoma patients undergoing curative-intent surgery[J]. Ann Surg Oncol, 2023, 30(2): 725-733. DOI: 10.1245/s10434-022-12494-0.
[8]刘小芳,汪清华,杨洪安,等.基于多序列MRI影像组学评分及临床参数预测肝细胞癌微血管浸润的nomogram模型研究[J].放射学实践, 2023, 38(8): 1018-1025. DOI:10.13609/j.cnki.1000-0313.2023.08.011.
[9]中国医师协会肝癌专业委员会.中国肝细胞癌合并门静脉癌栓诊疗指南(2021年版)[J].中华医学杂志, 2022, 102(4): 243-254. DOI:10.3760/cma.j.cn112137-20211117-02567.
[10]陈凤喜,蔡萍,刘晨,等.基于Gd-EOB-DTPA增强MRI的小肝癌微血管侵犯术前预测研究[J].局解手术学杂志, 2022, 31(8): 676-681. DOI:10.11659/jjssx.03E022092.
[11]Lee D H, Kim H, Hwang YJ, et al. FRI-310 - classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and MR imaging[J]. J Hepatol, 2023, 78:S512-S513. DOI: 10.3350/cmh.2023.0034.
[12]于航,郑忍成,李若坤,等.基于多任务网络的多模态肝脏MRI配准方法研究[J].中国医学计算机成像杂志, 2023, 29(5): 516-523. DOI:10.3969/j.issn.1006-5741.2023.05.011.
[13]雷磊,李俊杰,王倩梅,等.基于Faster-RCNN的肝细胞癌与肝内胆管细胞癌多模态MR影像智能肿瘤识别与分类诊断模型构建[J].临床误诊误治, 2022, 35(1): 38-42. DOI:10.3969/j.issn.1002-3429.2022.01.010.
[14]顾萃华,潘仕文,邱珏,等.基于MRI的放射组学模型预测中晚期肝癌患者TACE后肿瘤反应[J].介入放射学杂志, 2024, 33(1): 63-68. DOI:10.3969/j.issn.1008-794X.2024.01.012.
[15]施莹,柏根基,孙阳.多模态MRI对肝硬化增生性结节与小肝癌的鉴别诊断价值探讨[J].实用肝脏病杂志, 2022, 25(5): 722-725. DOI:10.3969/j.issn.1672-5069.2022.05.029.
[16]Huan L, Dai Z, Jinxia P, et al. Dual-energy computed tomography iodine quantification combined with laboratory data for predicting microvascular invasion in hepatocellular carcinoma: a two-centre study[J]. Br J Radiol, 2024, 97(1160): 1467-1475 DOI: 10.1093/bjr/tqae116.
[17]谭亚兰,江海涛.多模态磁共振在肝细胞癌分化程度评估中的应用进展[J].肝胆胰外科杂志, 2022, 34(5): 315-320. DOI:10.11952/j.issn.1007-1954.2022.05.014.
[18]张盼盼,陈斐,王少青,等.多模态MRI在不典型肝脓肿,肝脏转移瘤和肿块型胆管细胞癌中的应用和鉴别诊断[J].医学影像学杂志, 2023, 33(6): 1035-1039.
[19]陈兵,宋超,吴玲巧,等.增强MRI多模态定量参数及DWI定量参数与原发性肝癌癌细胞恶性行为的相关性[J].中国临床医学影像杂志, 2024, 35(9): 633-637. DOI:10.12117/jccmi.2024.09.006.
[20]曹佳智,任佑祥,陈科,等.基于多模态超声图像的深度学习在鉴别诊断肝内胆管细胞癌与肝细胞癌中的应用[J].西部医学, 2023, 35(6): 916-922. DOI:10.3969/j.issn.1672-3511.2023.06.025.
[21]Sidaway P. Gastrointestinal cancer: adjuvant sintilimabeffective in high-risk HCC[J]. Nat Rev Clin Oncol, 2024, 21(3): 168-168.
[22]岳律,卓丽华,姚洪超,等. DWI、IVIM和DKI定量参数联合模型在HCC病理分级中的应用评估[J].临床放射学杂志, 2024, 43(8): 1358-1364.
[23]楼晓剑,何维新,项伟敏,等.基于体素内不相干运动扩散加权成像多模态磁共振技术对高危人群早期小肝癌诊断价值[J].临床军医杂志, 2024, 52(7): 721-724, 730. DOI:10.16680/j.1671-3826.2024.07.17.
[24]Zhang Y, Chen J, Yang C, et al. Preoperative prediction of microvascular invasion in hepatocellular carcinoma using diffusion-weighted imaging–based habitat imaging[J]. Eur Radiol, 2024, 34(5): 3215-3225. DOI: 10.1007/s00330-023-10339-2.
[25]中国医师协会介入医师分会临床诊疗指南专委会.肝细胞癌经动脉化疗栓塞抵抗及后续治疗专家共识[J].介入放射学杂志, 2022, 31(11): 1039-1044. DOI:10.3969/j.issn.1008-794X.2022.11.001.
|